Research Institute for Integrative Regenerative Biomedical Engineering, Dongguk University, Goyang 10326, Republic of Korea and Department of Orthopaedics, Dongguk University Ilsan Hospital, Goyang, Republic of Korea.
Research Institute for Integrative Regenerative Biomedical Engineering, Dongguk University, Goyang 10326, Republic of Korea.
Biomater Sci. 2019 Nov 1;7(11):4588-4602. doi: 10.1039/c9bm01037h. Epub 2019 Aug 22.
While bone has the capability to heal itself, there is a great difficulty in reconstituting large bone defects created by heavy trauma or the resection of malignant tumors. Also, osteonecrosis of the femoral head (ONFH), which is caused by obstruction of the blood supply to bone cells and occurs in the young, is not amenable for successful bone regeneration. We developed VEGF- and BMP2-transfected adipose stem cells (ASCs) using electroporation that can effectively treat bone defects by providing rapid angiogenesis and osteogenesis. The optimal ratio of BMP2- to VEGF-transfected ASCs to enhance both osteogenesis and angiogenesis was 9 : 1. BMP2-/VEGF-transfected ASCs administered in this ratio effectively healed critical-size calvarial defects and long-bone segmental defects in immunosuppressed rats. The implanted cells did not migrate out of the implantation site by the 56th day. TAZ, TEAD, and ANKRD1 were overexpressed in BMP2-/VEGF-transfected ASCs, possibly proposing the mechanism of enhanced bone regeneration and angiogenesis. Our results suggest the possibility of using gene-cell therapy that can induce rapid angiogenesis and osteogenesis in inhospitable avascular environments including large bone defects and ONFH.
虽然骨骼具有自我修复的能力,但对于由严重创伤或恶性肿瘤切除造成的大骨缺损的重建仍然存在很大的困难。此外,由骨细胞供血阻塞引起的、发生于年轻人的股骨头坏死(ONFH)也不利于成功的骨再生。我们使用电穿孔技术开发了转染 VEGF 和 BMP2 的脂肪干细胞(ASCs),通过快速血管生成和成骨作用有效地治疗骨缺损。为了增强成骨和成血管作用,最佳的 BMP2-转染 ASCs 与 VEGF-转染 ASCs 的比例为 9∶1。在该比例下给予 BMP2-/VEGF-转染 ASCs 可有效治愈免疫抑制大鼠的临界尺寸颅骨缺损和长骨节段性缺损。在第 56 天,植入的细胞没有从植入部位迁移。BMP2-/VEGF-转染 ASCs 中过表达了 TAZ、TEAD 和 ANKRD1,这可能提出了增强骨再生和血管生成的机制。我们的结果表明,在包括大骨缺损和 ONFH 在内的无血管环境中,使用能够诱导快速血管生成和骨生成的基因细胞治疗是可能的。